Literature DB >> 17524980

Molecular similarity analysis uncovers heterogeneous structure-activity relationships and variable activity landscapes.

Lisa Peltason1, Jürgen Bajorath.   

Abstract

We systematically compare X-ray structures of inhibitor complexes of four well-known enzymes and correlate two- and three-dimensional (2D and 3D) similarity of inhibitors with their potency. The analysis reveals the presence of unexpected systematic relationships between molecular similarity and potency. These findings explain why apparently inconsistent structure-activity relationships (SARs) can coexist in different targets, and they have general implications for compound screening and optimization. The results suggest that (1) even for active sites with significant binding constraints, there is a high probability that structurally diverse ligands with similar activity can be identified, (2) different types of SARs are not mutually exclusive, and (3) the chemical nature of ligands is of comparable importance for SARs as the features of active sites. These insights aid in the understanding of target-specific SARs and their intrinsic degree of variability.

Mesh:

Substances:

Year:  2007        PMID: 17524980     DOI: 10.1016/j.chembiol.2007.03.011

Source DB:  PubMed          Journal:  Chem Biol        ISSN: 1074-5521


  11 in total

Review 1.  Fragment-based QSAR: perspectives in drug design.

Authors:  Lívia B Salum; Adriano D Andricopulo
Journal:  Mol Divers       Date:  2009-01-31       Impact factor: 2.943

2.  Binding mode similarity measures for ranking of docking poses: a case study on the adenosine A2A receptor.

Authors:  Andrew Anighoro; Jürgen Bajorath
Journal:  J Comput Aided Mol Des       Date:  2016-06-22       Impact factor: 3.686

3.  Structure-based predictions of activity cliffs.

Authors:  Jarmila Husby; Giovanni Bottegoni; Irina Kufareva; Ruben Abagyan; Andrea Cavalli
Journal:  J Chem Inf Model       Date:  2015-05-11       Impact factor: 4.956

4.  Estimation of the applicability domain of kernel-based machine learning models for virtual screening.

Authors:  Nikolas Fechner; Andreas Jahn; Georg Hinselmann; Andreas Zell
Journal:  J Cheminform       Date:  2010-03-11       Impact factor: 5.514

5.  Psoralen Derivatives with Enhanced Potency.

Authors:  Alexandru D Buhimschi; David M Gooden; Hongwu Jing; Diane R Fels; Katherine S Hansen; Wayne F Beyer; Mark W Dewhirst; Harold Walder; Francis P Gasparro
Journal:  Photochem Photobiol       Date:  2020-06-24       Impact factor: 3.421

6.  Compound Ranking Based on Fuzzy Three-Dimensional Similarity Improves the Performance of Docking into Homology Models of G-Protein-Coupled Receptors.

Authors:  Andrew Anighoro; Jürgen Bajorath
Journal:  ACS Omega       Date:  2017-06-08

7.  5-O-methylcneorumchromone K Exerts Antinociceptive Effects in Mice via Interaction with GABAA Receptors.

Authors:  Luiza Carolina França Opretzka; Humberto Fonseca de Freitas; Renan Fernandes Espírito-Santo; Lucas Silva Abreu; Iura Muniz Alves; Josean Fechine Tavares; Eudes da Silva Velozo; Marcelo Santos Castilho; Cristiane Flora Villarreal
Journal:  Int J Mol Sci       Date:  2021-03-26       Impact factor: 5.923

8.  In silico identification of anti-cancer compounds and plants from traditional Chinese medicine database.

Authors:  Shao-Xing Dai; Wen-Xing Li; Fei-Fei Han; Yi-Cheng Guo; Jun-Juan Zheng; Jia-Qian Liu; Qian Wang; Yue-Dong Gao; Gong-Hua Li; Jing-Fei Huang
Journal:  Sci Rep       Date:  2016-05-05       Impact factor: 4.379

9.  Enhance the performance of current scoring functions with the aid of 3D protein-ligand interaction fingerprints.

Authors:  Jie Liu; Minyi Su; Zhihai Liu; Jie Li; Yan Li; Renxiao Wang
Journal:  BMC Bioinformatics       Date:  2017-07-18       Impact factor: 3.169

10.  Using C. elegans Forward and Reverse Genetics to Identify New Compounds with Anthelmintic Activity.

Authors:  Mark D Mathew; Neal D Mathew; Angela Miller; Mike Simpson; Vinci Au; Stephanie Garland; Marie Gestin; Mark L Edgley; Stephane Flibotte; Aruna Balgi; Jennifer Chiang; Guri Giaever; Pamela Dean; Audrey Tung; Michel Roberge; Calvin Roskelley; Tom Forge; Corey Nislow; Donald Moerman
Journal:  PLoS Negl Trop Dis       Date:  2016-10-18
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.